Lipolytic Signaling + Fat Metabolism
AOD-9604 (Advanced Obesity Drug fragment 9604) is a modified fragment of human growth hormone designed to isolate and target its lipolytic (fat-reducing) properties without influencing growth pathways.
Developed to focus specifically on fat metabolism, AOD-9604 has been studied for its potential role in adipose tissue regulation and lipid breakdown — without stimulating systemic growth hormone activity.
Functional Focus
Targeted Lipolysis
Designed to stimulate fat metabolism pathways while avoiding broader anabolic signaling.
Adipose Regulation
Studied for its influence on stored fat breakdown, particularly in stubborn adiposity.
Metabolic Support
May assist in supporting energy utilization derived from lipid stores.
Non-Anabolic Mechanism
Does not promote growth hormone–mediated tissue proliferation.
Body Composition Refinement
Explored in research models focused on selective fat reduction.
Research Notes
AOD-9604 is investigational and has been studied for metabolic and fat-reduction applications. It is not FDA approved for weight loss or human consumption outside of research contexts. This compound is intended for laboratory research use only.